Gilman Hill Asset Management, LLC T2 Biosystems, Inc. Transaction History

Gilman Hill Asset Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 Apr 14, 2022	SELL	$0.36 - $0.57 $3,960 - $6,269	-11,000 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$0.46 - $0.94 $5,060 - $10,340	11,000 New	11,000 $6,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $5.99M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Gilman Hill Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gilman Hill Asset Management, LLC with notifications on news.